{"id":4401,"date":"2025-08-28T18:00:22","date_gmt":"2025-08-28T22:00:22","guid":{"rendered":"https:\/\/www.gensight-biologics.com\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\/"},"modified":"2026-09-24T00:05:40","modified_gmt":"2026-09-24T04:05:40","slug":"gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025","status":"publish","type":"post","link":"https:\/\/www.gensight-biologics.com\/fr\/2025\/08\/28\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\/","title":{"rendered":"GenSight Biologics reporte la publication de ses r\u00e9sultats financiers semestriels 2025"},"content":{"rendered":"\n<strong>Paris, France, le 28 ao\u00fbt 2025, 20h00 CEST<\/strong> \u2013 GenSight Biologics (\u00ab <strong>GenSight Biologics<\/strong> \u00bb ou la \u00ab <strong>Soci\u00e9t\u00e9<\/strong> \u00bb) (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et les troubles du syst\u00e8me nerveux central, annonce aujourd\u2019hui que la publication de ses r\u00e9sultats financiers semestriels, initialement pr\u00e9vue le 19 septembre 2025, est report\u00e9e au 29 septembre 2025, apr\u00e8s la cl\u00f4ture des march\u00e9s.\n\nCe report permet aux commissaires aux comptes de la Soci\u00e9t\u00e9 de finaliser l\u2019ensemble des proc\u00e9dures d\u2019audit n\u00e9cessaires conform\u00e9ment aux normes professionnelles les plus strictes. La Soci\u00e9t\u00e9 confirme que le report est uniquement li\u00e9 au calendrier de l\u2019audit et non \u00e0 des probl\u00e8mes concernant les \u00e9tats financiers. Il garantit ainsi le plein respect des exigences r\u00e9glementaires et permet \u00e0 la Soci\u00e9t\u00e9 de respecter ses obligations en termes \u00a0de communication financi\u00e8re rigoureuse et transparente.\n\nLes r\u00e9unions du Comit\u00e9 d\u2019audit et du Conseil d\u2019administration de la Soci\u00e9t\u00e9 ont donc \u00e9t\u00e9 reprogramm\u00e9es en cons\u00e9quence :\n<ul>\n \t<li>Comit\u00e9 d\u2019audit : report\u00e9e au 24 septembre 2025<\/li>\n \t<li>Conseil d\u2019administration : report\u00e9e au 26 septembre 2025<\/li>\n<\/ul>\nLes r\u00e9sultats semestriels seront mis \u00e0 disposition dans la <a href=\"https:\/\/www.gensight-biologics.com\/fr\/investisseurs-media\/\">rubrique relations investisseurs<\/a> du site internet de la Soci\u00e9t\u00e9, \u00e0 la suite de l\u2019annonce du 29 septembre 2025.\n","protected":false},"excerpt":{"rendered":"<p>Paris, France, le 28 ao\u00fbt 2025, 20h00 CEST \u2013 GenSight Biologics (\u00ab GenSight Biologics \u00bb ou la \u00ab Soci\u00e9t\u00e9 \u00bb) (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et les troubles du syst\u00e8me nerveux central, [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[54],"tags":[],"featured-area":[],"news-topic":[83],"news-type":[80],"post-year":[],"class_list":["post-4401","post","type-post","status-publish","format-standard","hentry","category-communiques-de-presse-financiers","news-topic-other","news-type-finance"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GenSight Biologics reporte la publication de ses r\u00e9sultats financiers semestriels 2025 - GenSight Biologics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2025\/08\/28\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GenSight Biologics reporte la publication de ses r\u00e9sultats financiers semestriels 2025 - GenSight Biologics\" \/>\n<meta property=\"og:description\" content=\"Paris, France, le 28 ao\u00fbt 2025, 20h00 CEST \u2013 GenSight Biologics (\u00ab GenSight Biologics \u00bb ou la \u00ab Soci\u00e9t\u00e9 \u00bb) (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et les troubles du syst\u00e8me nerveux central, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gensight-biologics.com\/fr\/2025\/08\/28\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"GenSight Biologics\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T22:00:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-24T04:05:40+00:00\" \/>\n<meta name=\"author\" content=\"jbenedicto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"jbenedicto\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2025\\\/08\\\/28\\\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2025\\\/08\\\/28\\\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\\\/\"},\"author\":{\"name\":\"jbenedicto\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"headline\":\"GenSight Biologics reporte la publication de ses r\u00e9sultats financiers semestriels 2025\",\"datePublished\":\"2025-08-28T22:00:22+00:00\",\"dateModified\":\"2026-09-24T04:05:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2025\\\/08\\\/28\\\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\\\/\"},\"wordCount\":245,\"articleSection\":[\"Communiqu\u00e9 de presse Financier\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2025\\\/08\\\/28\\\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\\\/\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2025\\\/08\\\/28\\\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\\\/\",\"name\":\"GenSight Biologics reporte la publication de ses r\u00e9sultats financiers semestriels 2025 - GenSight Biologics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\"},\"datePublished\":\"2025-08-28T22:00:22+00:00\",\"dateModified\":\"2026-09-24T04:05:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2025\\\/08\\\/28\\\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2025\\\/08\\\/28\\\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2025\\\/08\\\/28\\\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GenSight Biologics reporte la publication de ses r\u00e9sultats financiers semestriels 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/\",\"name\":\"GenSight Biologics\",\"description\":\"Restoring vision while advancing gene therapy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\",\"name\":\"jbenedicto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"caption\":\"jbenedicto\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GenSight Biologics reporte la publication de ses r\u00e9sultats financiers semestriels 2025 - GenSight Biologics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gensight-biologics.com\/fr\/2025\/08\/28\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\/","og_locale":"fr_FR","og_type":"article","og_title":"GenSight Biologics reporte la publication de ses r\u00e9sultats financiers semestriels 2025 - GenSight Biologics","og_description":"Paris, France, le 28 ao\u00fbt 2025, 20h00 CEST \u2013 GenSight Biologics (\u00ab GenSight Biologics \u00bb ou la \u00ab Soci\u00e9t\u00e9 \u00bb) (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et les troubles du syst\u00e8me nerveux central, [&hellip;]","og_url":"https:\/\/www.gensight-biologics.com\/fr\/2025\/08\/28\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\/","og_site_name":"GenSight Biologics","article_published_time":"2025-08-28T22:00:22+00:00","article_modified_time":"2026-09-24T04:05:40+00:00","author":"jbenedicto","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"jbenedicto","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.gensight-biologics.com\/fr\/2025\/08\/28\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\/#article","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2025\/08\/28\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\/"},"author":{"name":"jbenedicto","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"headline":"GenSight Biologics reporte la publication de ses r\u00e9sultats financiers semestriels 2025","datePublished":"2025-08-28T22:00:22+00:00","dateModified":"2026-09-24T04:05:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2025\/08\/28\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\/"},"wordCount":245,"articleSection":["Communiqu\u00e9 de presse Financier"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.gensight-biologics.com\/fr\/2025\/08\/28\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\/","url":"https:\/\/www.gensight-biologics.com\/fr\/2025\/08\/28\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\/","name":"GenSight Biologics reporte la publication de ses r\u00e9sultats financiers semestriels 2025 - GenSight Biologics","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#website"},"datePublished":"2025-08-28T22:00:22+00:00","dateModified":"2026-09-24T04:05:40+00:00","author":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"breadcrumb":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2025\/08\/28\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gensight-biologics.com\/fr\/2025\/08\/28\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.gensight-biologics.com\/fr\/2025\/08\/28\/gensight-biologics-reporte-la-publication-de-ses-resultats-financiers-semestriels-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gensight-biologics.com\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"GenSight Biologics reporte la publication de ses r\u00e9sultats financiers semestriels 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.gensight-biologics.com\/fr\/#website","url":"https:\/\/www.gensight-biologics.com\/fr\/","name":"GenSight Biologics","description":"Restoring vision while advancing gene therapy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gensight-biologics.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f","name":"jbenedicto","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","caption":"jbenedicto"}}]}},"_links":{"self":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/4401","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/comments?post=4401"}],"version-history":[{"count":2,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/4401\/revisions"}],"predecessor-version":[{"id":7055,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/4401\/revisions\/7055"}],"wp:attachment":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/media?parent=4401"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/categories?post=4401"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/tags?post=4401"},{"taxonomy":"featured-area","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/featured-area?post=4401"},{"taxonomy":"news-topic","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-topic?post=4401"},{"taxonomy":"news-type","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-type?post=4401"},{"taxonomy":"post-year","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/post-year?post=4401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}